|
|
Volumn 10, Issue 2 Suppl 1, 2007, Pages 5-9
|
|
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
BENZAZEPINE DERIVATIVE;
NEUROTRANSMITTER UPTAKE INHIBITOR;
NICOTINIC AGENT;
NORTRIPTYLINE;
QUINOXALINE DERIVATIVE;
VARENICLINE;
CARDIOVASCULAR DISEASE;
DIRECTIVE COUNSELING;
HOSPITALIZATION;
HUMAN;
METHODOLOGY;
PATIENT REFERRAL;
REVIEW;
RISK REDUCTION;
SMOKING;
SMOKING CESSATION;
BENZAZEPINES;
BUPROPION;
CARDIOVASCULAR DISEASES;
DIRECTIVE COUNSELING;
HOSPITALIZATION;
HUMANS;
NEUROTRANSMITTER UPTAKE INHIBITORS;
NICOTINIC AGONISTS;
NORTRIPTYLINE;
QUINOXALINES;
REFERRAL AND CONSULTATION;
RISK REDUCTION BEHAVIOR;
SMOKING;
SMOKING CESSATION;
MLCS;
MLOWN;
|
|
EID: 34447513144
PISSN: 1520037X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1520-037x.2007.06525.x Document Type: Review |
|
Times cited : (7)
|
|
References (47)
|
